Natural Course, Therapeutic Options and Economic Evaluation of Therapies for Chronic Hepatitis B

ISSN： 0012-6667

Source： Drugs, Vol.66, Iss.14, 2006-01, pp. : 1831-1851

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapies for chronic hepatitis B in paediatric patients

Inpharma, Vol. 1, Iss. 1343, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Evolving therapies for the treatment of chronic hepatitis B virus infection

By IV William E Delaney Bartholomeusz Angeline Locarnini Stephen A

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 2, 2002-02 ,pp. : 169-187

Informa Healthcare

Access to resources Recommend Favorite

Hepatitis C: Cost of Illness and Considerations for the Economic Evaluation of Antiviral Therapies

By Wong John B.

PharmacoEconomics, Vol. 24, Iss. 7, 2006-01 ,pp. : 661-672

Adis International

Access to resources Recommend Favorite

Lamivudine: A Review of its Therapeutic Potential in Chronic Hepatitis B

By Jarvis B. Faulds D.

Drugs, Vol. 58, Iss. 1, 1999-07 ,pp. : 101-141

Adis International

Access to resources Recommend Favorite

Antiviral Natural Products Against Chronic Hepatitis B: Recent Developments

Current Pharmaceutical Design, Vol. 22, Iss. 3, 2016-01 ,pp. : 286-293

Bentham Science Publishers

Access to resources Recommend Favorite